Yokohama, Japan

Hiromi Watanabe

This inventor holds 1 USPTO granted patent. Top assignee: Meiji Seika Kabushiki Kaisha. Active years: 1995.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hiromi Watanabe. Retrieved from https://idiyas.com/inventor/hiromi-watanabe-a5eqyod1

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 10.0

ph-index = 1

Forward Citations = 34(Granted Patents)


Company Filing History:


Years Active: 1995

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Hiromi Watanabe: Innovator in Pyridine Derivatives

Introduction

Hiromi Watanabe is a notable inventor based in Yokohama, Japan. He has made significant contributions to the field of chemistry, particularly in the development of pyridine derivatives. His work has implications for medical science, especially in the area of angiotensin II antagonism.

Latest Patents

Watanabe holds a patent for pyridine derivatives that exhibit angiotensin II antagonism. This patent is a testament to his innovative approach and dedication to advancing chemical research. He has 1 patent to his name, showcasing his expertise in this specialized area.

Career Highlights

Watanabe is currently employed at Meiji Seika Kabushiki Kaisha, a company known for its commitment to research and development in the pharmaceutical sector. His role at the company allows him to explore new avenues in chemical innovation and contribute to the advancement of medical treatments.

Collaborations

Throughout his career, Watanabe has collaborated with talented individuals such as Kiyoaki Katano and Hiroko Ogino. These collaborations have enriched his research and fostered a creative environment for innovation.

Conclusion

Hiromi Watanabe's work in pyridine derivatives highlights his role as a key innovator in the field of chemistry. His contributions continue to influence medical research and development, making him a significant figure in his industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…